Skip to main content

Altogen Biosystems' Xenograft Models for Transfection Research

Altogen Biosystems is a recognized provider and laboratory for the pharmaceutical industry. Custom research services and additional goods include xenografts, cell transfection optimization, 28-day generation of stably-transfected cells, IND applications and more. Dedicated to assisting customers with cutting-edge and efficient services, Altogen Biosystems endeavors to advance modern laboratory techniques. Visit the official website for a Caki-1 xenograft model.

Comments

Post a Comment

Popular posts from this blog

Caki-1 Transfection Reagent (Kidney Epithelial Cells)

The Caki-1 cell line was established from the renal carcinoma cells of a 49-year-old male patient with clear cell carcinoma. Caki-1 cells contain many microvilli, small mitochondria,and well developed endoplasmic reticulum (ER) and golgi apparatus. This cell line is not commercially available and is only available for research purposes. Transfection of the Caki-1 cell is facilitated by Caki-1 transfection reagents ( Altogen biosystems )  to establish stable cell lines, produce consistent research and to optimize transfection of siRNA, miRNA and pDNA.  Caki-1 Transfection Reagent (Kidney Epithelial Cells)
Post a Comment
Read more

Metformin Induces Various Responses in Caki-1 and Caki-2 Cells

Clear cell renal cell carcinoma (ccRCC) is one of the most common urological cancers diagnosed globally. Two cell lines that derive from human ccRCC are Caki-1 and Caki-2, which express wild-type VHL (von Hippel-Lindau). Defining characteristics of ccRCC include the mutation of the VHL tumor suppressor gene and the overexpression of hypoxia-inducible factor (HIF)-1 α protein.  Previous studies have suggested that metformin (a drug used to treat diabetes) exhibit antineoplastic effects in different types of cancers since its activation of AMPK evidently decreases the expression of HIF-1 α.  In this study, researchers analyze the effect of metformin on both Caki-1 and Caki-2 cell lines. Several concentrations of Metformin were used to treat the cell lines, and various assays and analyses were used to observe cell viability, cell cycle arrest, migration, and apoptosis. Results from this study indicate that Metformin inhibited cell growth in both Caki-1 and Caki-2 cell lines. Howe...
Post a Comment
Read more

Kidney Cancer Research Through Caki-1 Cells

Clear-cell carcinomas are some of the most common renal cancers observed in humans. Current medical efforts at finding cures to the cancer focus on the responses of it to the inhibition of  RAF-1, VEGR and PDGFR, all found in the Caki-1 cell line. Through transfection experiments with appropriate reagents , researchers can examine the possibilities of genetic modification and its ramifications on the physiology of Caki-1, leading to reliable results that can inform preclinical trials and commercial drug development.
Post a Comment
Read more